Data gathered: May 17
Alternative Data for Krystal Biotech
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 21 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 15,000 | Sign up | Sign up | Sign up |
| Employee Rating | 58 | Sign up | Sign up | Sign up |
| Google Trends | 8 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,627 | Sign up | Sign up | Sign up |
| Twitter Followers | 927 | Sign up | Sign up | Sign up |
| Twitter Mentions | 15 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 37 | Sign up | Sign up | Sign up |
| Linkedin Employees | 228 | Sign up | Sign up | Sign up |
About Krystal Biotech
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States.
| Price | $163.78 |
| Target Price | Sign up |
| Volume | 159,410 |
| Market Cap | $4.68B |
| Year Range | $96 - $180.42 |
| Dividend Yield | 0% |
| PE Ratio | 74.79 |
| Revenue per Employee | $859,050 |
| Industry | Biotechnology |
In the news
Krystal Biotech to Present at the American Thoracic Society 2024 International ConferenceMay 15 - GlobeNewswire |
|
 |
Krystal Biotech: VYJUVEK's Blockbuster Potential In Gene Therapy For DEBMay 14 - SeekingAlpha |
Krystal Biotech to present preclinical data on KB407, KB408May 14 - Thefly.com |
|
 |
Krystal Biotech, Inc. to Post FY2024 Earnings of $4.00 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:KRYS)May 12 - ETF Daily News |
|
Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Victory Capital Management Inc.May 10 - ETF Daily News |
|
William Blair Brokers Lift Earnings Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS)May 10 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 46M | 26M | 20M | 930,000 | 20M | 0.030 |
| Q4 '23 | 47M | 22M | 25M | 8.7M | 4.6M | 0.300 |
| Q3 '23 | 8.6M | 24M | -15M | 81M | -25M | -0.690 |
| Q2 '23 | 0 | 26M | -26M | -33M | -37M | -1.250 |
| Q1 '23 | 810,000 | 25M | -25M | -45M | -48M | -1.760 |
Insider Transactions View All
| Krishnan Krish S filed to sell 1,550,882 shares at $174.1. March 11 '24 |
| Krishnan Suma filed to sell 1,550,882 shares at $174.1. March 11 '24 |
| Krishnan Krish S filed to sell 1,612,262 shares at $174. March 11 '24 |
| Krishnan Krish S filed to sell 1,571,578 shares at $169. March 11 '24 |
| Krishnan Krish S filed to sell 1,635,116 shares at $168. March 11 '24 |
Similar companies
Read more about Krystal Biotech (KRYS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Krystal Biotech?
The Market Cap of Krystal Biotech is $4.68B.
What is Krystal Biotech's PE Ratio?
As of today, Krystal Biotech's PE (Price to Earnings) ratio is 74.79.
How Many People Work at Krystal Biotech?
As of our latest update, Krystal Biotech employed approximately 119 people worldwide. However, it's important to note that Krystal Biotech's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Krystal Biotech's revenue per employee?
$859,050. To calculate Krystal Biotech's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Krystal Biotech?
Currently, the price of one share of Krystal Biotech stock is $163.78.
How can I analyze the KRYS stock price chart for investment decisions?
The KRYS stock price chart above provides a comprehensive visual representation of Krystal Biotech's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Krystal Biotech shares. Our platform offers an up-to-date KRYS stock price chart, along with technical data analysis and alternative data insights.
Does KRYS offer dividends to its shareholders?
As of our latest update, Krystal Biotech (KRYS) does not offer dividends to its shareholders. Investors interested in Krystal Biotech should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Krystal Biotech?
Some of the similar stocks of Krystal Biotech are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.